Recros Medica
San Diego, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Recros Medica
Sign up to see every warm intro you have to Recros Medica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Recros Medica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DF
David F. HaleExecutive
KD
Kathleen D. ScottExecutive
EK
Edward Knowlton, M.D.Named on SEC filing
Board
MK
Milind K. Ambe, M.D.Board director
CM
Cathy McCarthyBoard director
Investors · 1
Funding
SEC filings, press & company announcements$23.9M disclosed across 4 rounds · 2014–2019
- $14MSeries ANov 2019 · 2 sourcesSource ↗
▶$4.1MraisedFeb 2019 · 47 investors · BiotechnologyRule 506(b)
▶$4.1MraisedFeb 2019 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward Knowlton, M.D.Executive Officer, Director
- Christoph WestphalDirector
- Thomas A. AlbrightExecutive Officer, Director
- Kathleen D. ScottExecutive Officer
- Cathy L. McCarthyDirector
- Milind K. Ambe, M.D.Director
- Mark J. KerslakeDirector
- David F. HaleDirector
- Offering amount
- $10M
- Amount sold
- $4.1M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4.4MraisedJul 2017 · 44 investors · BiotechnologyRule 506(b)
▶$4.4MraisedJul 2017 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward Knowlton, M.D.Executive Officer, Director
- David F. HaleDirector
- Milind K. Ambe, M.D.Director
- Cathy L. McCarthyDirector
- Kathleen D. ScottExecutive Officer
- Offering amount
- $9M
- Amount sold
- $4.4M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.4MraisedAug 2016 · 5 investors · BiotechnologyRule 506(b)
▶$1.4MraisedAug 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David F. HaleExecutive Officer, Director
- Edward Knowlton, M.D.Executive Officer, Director
- Milind K. Ambe, M.D.Director
- Kathleen D. ScottExecutive Officer
- Cathy McCarthyDirector
- Offering amount
- $1.9M
- Amount sold
- $1.4M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Recros Medica's investors?
- Recros Medica's investors include Longwood Fund.
- How much funding has Recros Medica raised?
- Recros Medica has disclosed $23.9M raised across 4 rounds.
- Where is Recros Medica headquartered?
- Recros Medica is headquartered in San Diego, US.